| |
| |
|
| Insider
Information: |
Quart Barry D |
| Relationship: |
|
| City: |
Lafayette |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
182,989 |
|
|
Indirect Shares
|
2,500 |
|
|
| Direct
Value |
$785,588 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
185,489 |
|
|
| Total
Value |
$785,588 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 4.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ardea Biosciences Inc |
RDEA |
President and CEO, Dir... |
2012-06-19 |
0 |
2009-05-27 |
2,500 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
Chief Executive Office... |
2023-01-13 |
177,989 |
2016-11-04 |
0 |
Premium* |
|
|
Synageva BioPharma Corp |
GEVA |
|
2014-06-20 |
0 |
2014-06-12 |
0 |
Premium* |
|
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2023-06-29 |
5,000 |
2022-11-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
89 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2018-06-21 |
4 |
AS |
$39.05 |
$1,952,500 |
D/D |
(50,000) |
69,600 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2013-11-20 |
4 |
B |
$0.40 |
$400,000 |
D/D |
1,000,000 |
1,037,100 |
2.81 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2014-06-25 |
4 |
B |
$11.75 |
$117,500 |
D/D |
10,000 |
61,855 |
2.81 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2019-10-03 |
4 |
B |
$17.50 |
$79,993 |
D/D |
4,571 |
94,652 |
2.81 |
- |
|
| RDEA |
Ardea Biosciences Inc |
President and CEO |
• • – |
2012-06-19 |
4 |
D |
$32.00 |
$1,387,136 |
D/D |
(43,348) |
0 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2021-01-13 |
4 |
D |
$18.16 |
$17,488 |
D/D |
(963) |
91,909 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2021-04-13 |
4 |
D |
$16.66 |
$16,044 |
D/D |
(963) |
95,192 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2021-07-13 |
4 |
D |
$13.48 |
$12,981 |
D/D |
(963) |
99,403 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2021-10-13 |
4 |
D |
$10.55 |
$10,160 |
D/D |
(963) |
102,086 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2022-01-13 |
4 |
D |
$8.30 |
$43,318 |
D/D |
(5,219) |
116,635 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2022-07-13 |
4 |
D |
$3.01 |
$15,709 |
D/D |
(5,219) |
147,237 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2022-10-13 |
4 |
D |
$3.76 |
$19,623 |
D/D |
(5,219) |
161,786 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2023-01-13 |
4 |
D |
$3.17 |
$16,544 |
D/D |
(5,219) |
177,989 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
President and CEO |
• • – |
2009-05-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,500 |
2,500 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2016-11-04 |
4 |
GA |
$0.00 |
$0 |
D/D |
600 |
92,509 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
President and CEO |
• • – |
2009-05-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
16,511 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
President and CEO |
• • – |
2009-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,500 |
21,515 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
President and CEO |
• • – |
2010-09-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
37,202 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
President and CEO |
• • – |
2011-11-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
52,889 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
President and CEO |
• • – |
2011-12-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
42,889 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2014-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,928 |
52,868 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2015-12-29 |
5 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
57,370 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2016-11-04 |
4 |
GD |
$0.00 |
$0 |
I/I |
600 |
0 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2012-06-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
37,100 |
|
- |
|
| RDEA |
Ardea Biosciences Inc |
President and CEO |
• • – |
2008-09-03 |
4 |
OE |
$3.90 |
$58,500 |
D/D |
15,000 |
15,503 |
0 |
- |
|
89 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
